세계의 신생아 케어 장비 시장 : 제품별, 최종사용자별, 지역별 - 예측(-2030년)

The neonatal care equipment market is projected to reach USD 2.84 billion by 2030 from USD 2.06 billion in 2025, at a CAGR of 5.6% during the forecast period.

Technological advancements in neonatal care equipment are significantly transforming the landscape of newborn healthcare. Innovations such as hybrid warmer-incubator systems combine the benefits of open warmers and closed incubators, offering flexibility and reducing the need to transfer fragile infants between devices. Automated oxygen delivery systems enable precise and real-time regulation of oxygen levels, minimizing risks associated with hypoxia or hyperoxia. Integrated phototherapy units, embedded within incubators or warmers, allow for continuous treatment of neonatal jaundice without disturbing the infant.

Additionally, wireless monitoring systems enhance mobility, reduce cable clutter, and lower the risk of infection, all while providing seamless and accurate real-time data. These advanced technologies are not only improving clinical outcomes for premature and critically ill neonates but are also driving hospitals and neonatal intensive care units (NICUs) to upgrade their infrastructure. As a result, these innovations are fueling consistent growth in the global neonatal care equipment market by enhancing efficiency, safety, and care quality.

Based on product, the neonatal incubators segment held the largest share of the global neonatal care equipment market in 2024. Preterm and low-birth-weight infants lack the ability to regulate their body temperature, making them highly vulnerable to hypothermia. Neonatal incubators play a critical role in providing a stable and controlled thermal environment that supports survival, growth, and development in these infants. As a result, incubators are a vital component of Neonatal Intensive Care Units (NICUs). Owing to their essential role in managing preterm births, the neonatal incubators segment holds the largest market share in the neonatal care equipment market.

Based on end users, general hospitals held the largest market share in the neonatal care equipment market in 2024. General hospitals act as the primary access point for neonatal deliveries, particularly in developing and middle-income countries where specialized pediatric centers are limited. They manage a high volume of both routine and high-risk childbirths, necessitating the availability of comprehensive neonatal care equipment. Their broad service coverage and accessibility make them central to neonatal care delivery. Consequently, the general hospitals segment accounts for the largest market share in the neonatal care equipment market, driven by consistent demand and widespread patient inflow.

North America is expected to account for the largest share of the neonatal care equipment market during the forecast period. North America, particularly the US and Canada, leads the neonatal care equipment market due to high healthcare spending and strong reimbursement frameworks. A substantial share of GDP is dedicated to healthcare, ensuring well-equipped neonatal units. Programs such as Medicaid, Medicare, and private insurance facilitate access to advanced and often expensive devices such as incubators, ventilators, and monitors. This robust financial and infrastructural support enables widespread adoption of cutting-edge neonatal technologies, positioning North America as the dominant regional market for neonatal care equipment.

A breakdown of the primary participants (supply-side) for the neonatal care equipment market referred to in this report is provided below:

• By Company Type: Tier 1:34%, Tier 2: 38%, and Tier 3: 28%
• By Designation: C Level: 26%, Director Level: 35%, and Others: 39%
• By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5%

Prominent players in the neonatal care equipment market are GE Healthcare (US), Dragerwerk AG & Co. KGaA (Germany), Koninklijke Philips N.V. (Netherlands), Masimo (US), Fisher & Paykel Healthcare (New Zealand)

Research Coverage

The report evaluates the neonatal care equipment market and estimates the market size and future growth potential based on various segments, including product, end user, and region. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will assist the market leader/new entrants in the market with data on the nearest approximations of the revenue numbers for the overall neonatal care equipment market and the subsegments. The report will assist stakeholders in understanding the competitive landscape and gaining further insights into better placing their businesses and making appropriate go-to-market strategies. The report assists the stakeholders in understanding the market pulse and gives them data on influential drivers, hindrances, obstacles, and opportunities in the market.

This report provides insights into the following points:

• Analysis of key drivers (rising number of preterm and low-weight births, public-private initiatives to strengthen patient care, increasing incidence of HAIs among newborns, changing clinical risks for congenital and obstetric complications, growing number of neonatal care facilities worldwide), restraints (premium pricing of advanced neonatal care equipment, growing preference for refurbished devices across emerging countries), opportunities (development of integrated and multifunctional neonatal care equipment, market opportunities in emerging economies) and challenges (limited access in low-income regions, regulatory and compliance complexities)
• Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global neonatal care equipment market
• Market Development: Thorough knowledge and analysis of the profitable rising markets by product, end user, and region
• Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global neonatal care equipment market
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global neonatal care equipment market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATON & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key sources of secondary data
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key objectives of primary research
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
  • 2.2.2 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS
  • 2.2.3 DEMAND-SIDE ANALYSIS
  • 2.2.4 TOP-DOWN APPROACH
• 2.3 DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 STUDY ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 NEONATAL CARE EQUIPMENT MARKET OVERVIEW
• 4.2 ASIA PACIFIC: NEONATAL CARE EQUIPMENT MARKET, BY PRODUCT AND COUNTRY
• 4.3 NEONATAL CARE EQUIPMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 NEONATAL CARE EQUIPMENT MARKET, REGIONAL MIX, 2023-2030
• 4.5 NEONATAL CARE EQUIPMENT MARKET: EMERGING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising number of preterm and low-weight births
    • 5.2.1.2 Increased public-private initiatives for better patient care
    • 5.2.1.3 Growing incidence of healthcare-associated infections (HAIs) among newborns
    • 5.2.1.4 Changing clinical risks in congenital and obstetric complications
    • 5.2.1.5 Increasing number of neonatal care facilities worldwide
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Premium pricing of advanced neonatal care equipment
    • 5.2.2.2 Growing preference for refurbished devices in emerging economies
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Development of integrated and multifunctional neonatal care equipment
    • 5.2.3.2 High growth opportunities in emerging economies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Limited access to neonatal care in low-income regions
    • 5.2.4.2 Regulatory and compliance complexities
• 5.3 INDUSTRY TRENDS
  • 5.3.1 INTEGRATION OF ADVANCED MATERIALS AND SUSTAINABILITY INITIATIVES
  • 5.3.2 SHIFT TOWARD PROCEDURE-SPECIFIC STERILE KITS AND MODULAR DESIGNS
• 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.5 PRICING ANALYSIS
  • 5.5.1 AVERAGE SELLING PRICE TREND OF NEONATAL CARE PRODUCTS, BY KEY PLAYER, 2022-2024
  • 5.5.2 AVERAGE SELLING PRICE TREND OF NEONATAL INCUBATORS, BY REGION, 2022-2024
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 SUPPLY CHAIN ANALYSIS
• 5.8 ECOSYSTEM ANALYSIS
  • 5.8.1 ROLE IN ECOSYSTEM
• 5.9 INVESTMENT & FUNDING SCENARIO
• 5.10 TECHNOLOGY ANALYSIS
  • 5.10.1 KEY TECHNOLOGIES
    • 5.10.1.1 Advanced neonatal ventilation and CPAP systems
    • 5.10.1.2 Phototherapy technologies (LED and fiber-optic)
  • 5.10.2 COMPLEMENTARY TECHNOLOGIES
    • 5.10.2.1 Heated humidifiers and respiratory gas conditioning units
  • 5.10.3 ADJACENT TECHNOLOGIES
    • 5.10.3.1 Point-of-care diagnostics (POCT)
    • 5.10.3.2 Fetal monitoring systems
• 5.11 PATENT ANALYSIS
  • 5.11.1 INNOVATIONS AND PATENT REGISTRATIONS, 2023-2025
• 5.12 TRADE ANALYSIS
  • 5.12.1 IMPORT DATA FOR HS CODE 901890
  • 5.12.2 EXPORT DATA FOR HS CODE 901890
• 5.13 KEY CONFERENCES & EVENTS, 2025-2026
• 5.14 CASE STUDY ANALYSIS
  • 5.14.1 BOSTON CHILDREN'S HOSPITAL TO MODERNIZE NICU INFRASTRUCTURE FOR IMPROVED CARE AMONG PREMATURE INFANTS
  • 5.14.2 INDIAN MINISTRY OF HEALTH TO DEPLOY LOW-COST LED PHOTOTHERAPY UNITS FOR REDUCING NEONATAL JAUNDICE-RELATED MORTALITY
  • 5.14.3 MOUNT SINAI HOSPITAL TO IMPLEMENT PREDICTIVE NEONATAL MONITORING FOR REDUCING LATE-ONSET SEPSIS AND APNEA IN PRETERM INFANTS
• 5.15 REGULATORY ANALYSIS
  • 5.15.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.15.2 REGULATORY LANDSCAPE
    • 5.15.2.1 North America
      • 5.15.2.1.1 US
      • 5.15.2.1.2 Canada
    • 5.15.2.2 Europe
    • 5.15.2.3 Asia Pacific
      • 5.15.2.3.1 China
      • 5.15.2.3.2 Japan
      • 5.15.2.3.3 India
    • 5.15.2.4 Latin America
      • 5.15.2.4.1 Brazil
      • 5.15.2.4.2 Mexico
    • 5.15.2.5 Middle East
    • 5.15.2.6 Africa
• 5.16 PORTER'S FIVE FORCES ANALYSIS
  • 5.16.1 BARGAINING POWER OF SUPPLIERS
  • 5.16.2 BARGAINING POWER OF BUYERS
  • 5.16.3 THREAT OF NEW ENTRANTS
  • 5.16.4 THREAT OF SUBSTITUTES
  • 5.16.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.17 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.17.2 BUYING CRITERIA
• 5.18 UNMET NEEDS/END-USER EXPECTATIONS
• 5.19 ADJACENT MARKET ANALYSIS
• 5.20 IMPACT OF AI/GEN AI ON NEONATAL CARE EQUIPMENT MARKET
  • 5.20.1 MARKET POTENTIAL OF AI/GEN AI
  • 5.20.2 AI USE CASES
  • 5.20.3 KEY COMPANIES IMPLEMENTING AI
  • 5.20.4 FUTURE OF AI/GEN AI
• 5.21 IMPACT OF 2025 US TARIFF ON NEONATAL CARE EQUIPMENT MARKET
  • 5.21.1 KEY TARIFF RATES
  • 5.21.2 PRICE IMPACT ANALYSIS
  • 5.21.3 IMPACT ON END-USE INDUSTRIES

6 NEONATAL CARE EQUIPMENT MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 NEONATAL INCUBATORS
  • 6.2.1 HIGH PRETERM BIRTH BURDEN AND INCREASED TECH INTEGRATION TO AID MARKET GROWTH
• 6.3 NEONATAL RESPIRATORY CARE DEVICES
  • 6.3.1 NEONATAL VENTILATORS
    • 6.3.1.1 Increasing burden of neonatal respiratory distress syndrome to augment segment growth
  • 6.3.2 CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES
    • 6.3.2.1 Development of affordable and non-invasive CPAP devices to aid global newborn care programs
  • 6.3.3 RESUSCITATORS
    • 6.3.3.1 Availability of advanced, low-cost kits to drive segment growth
  • 6.3.4 OTHER NEONATAL RESPIRATORY CARE DEVICES
• 6.4 CONVERTIBLE WARMERS & INCUBATORS
  • 6.4.1 MULTI-STAGE THERMAL CARE NEEDS AND REQUIRMENT FOR SPACE OPTIMIZATION TO BOOST DEMAND
• 6.5 NEONATAL PHOTOTHERAPY EQUIPMENT
  • 6.5.1 CONVENTIONAL NEONATAL PHOTOTHERAPY EQUIPMENT
    • 6.5.1.1 Affordability and accessibility to drive continued use of conventional neonatal phototherapy equipment
  • 6.5.2 FIBRE-OPTIC NEONATAL PHOTOTHERAPY EQUIPMENT
    • 6.5.2.1 Parent-friendly design and home-based care to accelerate market growth
• 6.6 NEONATAL MONITORING DEVICES
  • 6.6.1 BLOOD PRESSURE MONITORS
    • 6.6.1.1 Need for critical hemodynamic monitoring to boost adoption of neonatal blood pressure monitors
  • 6.6.2 CARDIAC MONITORS
    • 6.6.2.1 Non-invasive monitoring and early detection of cardiac issues to propel segment growth
  • 6.6.3 PULSE OXIMETERS
    • 6.6.3.1 Global push for universal newborn SpO2 screening and growing need for real-time oxygen titration in NICUs to spur market growth
  • 6.6.4 CAPNOGRAPHS
    • 6.6.4.1 High incidence of neonatal respiratory distress and emphasis on safe airway management in critical care to propel segment growth
  • 6.6.5 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS
    • 6.6.5.1 Rising incidence of meconium aspiration syndrome and persistent pulmonary hypertension to favor market growth
  • 6.6.6 INTEGRATED MONITORING DEVICES
    • 6.6.6.1 Real-time vital tracking and AI integration to drive segment growth
• 6.7 NEONATAL DIAGNOSTIC IMAGING COMPONENTS
  • 6.7.1 ULTRASOUND TRANSDUCERS
    • 6.7.1.1 Increasing use of point-of-care ultrasound (POCUS) in NICUs to propel market growth
  • 6.7.2 X-RAY DETECTORS
    • 6.7.2.1 Need for ultra-low dose and portable imaging to drive adoption of neonatal x-ray detectors in NICUs
• 6.8 INFANT WARMERS
  • 6.8.1 ELECTRIC WARMERS
    • 6.8.1.1 Tech-enabled and portable designs to drive demand for electric infant warmers in low-resource settings
  • 6.8.2 NON-ELECTRIC WARMERS
    • 6.8.2.1 Low-cost and power-free solutions to augment market growth
• 6.9 OTHER NEONATAL PRODUCTS

7 NEONATAL CARE EQUIPMENT MARKET, BY END USER

• 7.1 INTRODUCTION
• 7.2 GENERAL HOSPITALS
  • 7.2.1 LARGE PATIENT BASE AND INTEGRATED NICU FACILITIES TO AUGMENT MARKET GROWTH
• 7.3 PEDIATRIC HOSPITALS
  • 7.3.1 AVAILABILITY OF PEDIATRIC SPECIALISTS FOR CRITICAL NEONATAL CASES TO AID MARKET GROWTH
• 7.4 MATERNITY & BIRTHING CENTERS
  • 7.4.1 EXPANDING MATERNAL HEALTH COVERAGE AND POPULARITY OF MIDWIFE-LED BIRTHING MODELS TO DRIVE MARKET
• 7.5 OTHER END USERS

8 NEONATAL CARE EQUIPMENT MARKET, BY REGION

• 8.1 INTRODUCTION
• 8.2 NORTH AMERICA
  • 8.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 8.2.2 US
    • 8.2.2.1 US to dominate North American neonatal care equipment market during forecast period
  • 8.2.3 CANADA
    • 8.2.3.1 Strong public healthcare funding and expanding neonatal intensive care infrastructure to propel market growth
• 8.3 EUROPE
  • 8.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 8.3.2 GERMANY
    • 8.3.2.1 Public-private collaborations and increased focus on product innovations to fuel market growth
  • 8.3.3 FRANCE
    • 8.3.3.1 High healthcare spending and focus on domestic NICU manufacturing to aid market growth
  • 8.3.4 UK
    • 8.3.4.1 NHS-led digitization and high preterm care standards to drive neonatal care equipment modernization
  • 8.3.5 ITALY
    • 8.3.5.1 Regionally decentralized healthcare system to boost market growth
  • 8.3.6 SPAIN
    • 8.3.6.1 High healthcare spending and investments through the Digital Health Strategy to propel market growth
  • 8.3.7 REST OF EUROPE
• 8.4 ASIA PACIFIC
  • 8.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 8.4.2 JAPAN
    • 8.4.2.1 Low neonatal mortality and advanced health infrastructure to propel adoption of innovative neonatal care equipment
  • 8.4.3 CHINA
    • 8.4.3.1 High premature birth rates and favorable government initiatives to fuel market growth
  • 8.4.4 INDIA
    • 8.4.4.1 High birth volume, increased prevalence of preterm deliveries, and favorable public healthcare programs to drive market
  • 8.4.5 SOUTH KOREA
    • 8.4.5.1 Innovation-driven neonatal care and increased private maternity and pediatric clinics to favor market growth
  • 8.4.6 AUSTRALIA
    • 8.4.6.1 Advanced public health infrastructure and government prioritization of maternal & child health to drive market
  • 8.4.7 NEW ZEALAND
    • 8.4.7.1 Government-funded healthcare and maternal & child health equity reforms to drive neonatal care expansion
  • 8.4.8 REST OF ASIA PACIFIC
• 8.5 LATIN AMERICA
  • 8.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 8.5.2 BRAZIL
    • 8.5.2.1 Government-backed healthcare initiatives and active local manufacturing ecosystem to bolster market growth
  • 8.5.3 MEXICO
    • 8.5.3.1 Universal neonatal health coverage and expansion of NICUs to fuel market growth
  • 8.5.4 REST OF LATIN AMERICA
• 8.6 MIDDLE EAST & AFRICA
  • 8.6.1 HIGH BIRTH RATES AND REGIONAL HEALTH REFORMS TO CATALYZE NEONATAL EQUIPMENT DEMAND
  • 8.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
• 8.7 GCC COUNTRIES
  • 8.7.1 STRATEGIC GOVERNMENT SPENDING, ADOPTION OF SMART NICU TECHNOLOGIES, AND FOCUS ON DIGITAL MATERNAL-CHILD CARE TO DRIVE MARKET
  • 8.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

9 COMPETITIVE LANDSCAPE

• 9.1 INTRODUCTION
• 9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 9.2.1 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN NEONATAL CARE EQUIPMENT MARKET, 2021-2025
• 9.3 REVENUE ANALYSIS, 2020-2024
• 9.4 MARKET SHARE ANALYSIS, 2024
• 9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 9.5.1 STARS
  • 9.5.2 EMERGING LEADERS
  • 9.5.3 PERVASIVE PLAYERS
  • 9.5.4 PARTICIPANTS
  • 9.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 9.5.5.1 Company footprint
    • 9.5.5.2 Region footprint
    • 9.5.5.3 Product footprint
    • 9.5.5.4 End-user footprint
• 9.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 9.6.1 PROGRESSIVE COMPANIES
  • 9.6.2 RESPONSIVE COMPANIES
  • 9.6.3 DYNAMIC COMPANIES
  • 9.6.4 STARTING BLOCKS
  • 9.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 9.6.5.1 Detailed list of key startups/SMEs
    • 9.6.5.2 Competitive benchmarking of startups/SMEs
• 9.7 COMPANY VALUATION & FINANCIAL METRICS
  • 9.7.1 FINANCIAL METRICS
  • 9.7.2 COMPANY VALUATION
• 9.8 BRAND/PRODUCT COMPARISON
• 9.9 COMPETITIVE SCENARIO
  • 9.9.1 PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
  • 9.9.2 DEALS

10 COMPANY PROFILES

• 10.1 KEY PLAYERS
  • 10.1.1 GE HEALTHCARE
    • 10.1.1.1 Business overview
    • 10.1.1.2 Products offered
    • 10.1.1.3 Recent developments
      • 10.1.1.3.1 Product launches/approvals/enhancements
    • 10.1.1.4 MnM view
      • 10.1.1.4.1 Right to win
      • 10.1.1.4.2 Strategic choices
      • 10.1.1.4.3 Weaknesses & competitive threats
  • 10.1.2 DRAGERWERK AG & CO. KGAA
    • 10.1.2.1 Business overview
    • 10.1.2.2 Products offered
    • 10.1.2.3 Recent developments
      • 10.1.2.3.1 Product launches/approvals/enhancements
    • 10.1.2.4 MnM view
      • 10.1.2.4.1 Right to win
      • 10.1.2.4.2 Strategic choices
      • 10.1.2.4.3 Weaknesses & competitive threats
  • 10.1.3 KONINKLIJKE PHILIPS N.V.
    • 10.1.3.1 Business overview
    • 10.1.3.2 Products offered
    • 10.1.3.3 Recent developments
      • 10.1.3.3.1 Deals
    • 10.1.3.4 MnM view
      • 10.1.3.4.1 Right to win
      • 10.1.3.4.2 Strategic choices
      • 10.1.3.4.3 Weaknesses & competitive threats
  • 10.1.4 MASIMO
    • 10.1.4.1 Business overview
    • 10.1.4.2 Products offered
    • 10.1.4.3 Recent developments
      • 10.1.4.3.1 Deals
    • 10.1.4.4 MnM view
      • 10.1.4.4.1 Right to win
      • 10.1.4.4.2 Strategic choices
      • 10.1.4.4.3 Weaknesses & competitive threats
  • 10.1.5 FISHER & PAYKEL HEALTHCARE LIMITED
    • 10.1.5.1 Business overview
    • 10.1.5.2 Products offered
    • 10.1.5.3 MnM view
      • 10.1.5.3.1 Right to win
      • 10.1.5.3.2 Strategic choices
      • 10.1.5.3.3 Weaknesses & competitive threats
  • 10.1.6 NIHON KOHDEN CORPORATION
    • 10.1.6.1 Business overview
    • 10.1.6.2 Products offered
    • 10.1.6.3 Recent developments
      • 10.1.6.3.1 Product launches/approvals/enhancements
  • 10.1.7 INSPIRATION HEALTHCARE GROUP PLC
    • 10.1.7.1 Business overview
    • 10.1.7.2 Products offered
  • 10.1.8 MEDTRONIC
    • 10.1.8.1 Business overview
    • 10.1.8.2 Products offered
    • 10.1.8.3 Recent developments
      • 10.1.8.3.1 Product launches/approvals/enhancements
  • 10.1.9 CARDINAL HEALTH
    • 10.1.9.1 Business overview
    • 10.1.9.2 Products offered
  • 10.1.10 ICU MEDICAL, INC.
    • 10.1.10.1 Business overview
    • 10.1.10.2 Products offered
  • 10.1.11 UTAH MEDICAL PRODUCTS, INC.
    • 10.1.11.1 Business overview
    • 10.1.11.2 Products offered
  • 10.1.12 AMBU A/S
    • 10.1.12.1 Business overview
    • 10.1.12.2 Products offered
  • 10.1.13 BECTON, DICKINSON AND COMPANY (BD)
    • 10.1.13.1 Business overview
    • 10.1.13.2 Products offered
  • 10.1.14 ATOM MEDICAL CORP.
    • 10.1.14.1 Business overview
    • 10.1.14.2 Products offered
    • 10.1.14.3 Recent developments
      • 10.1.14.3.1 Other developments
  • 10.1.15 HAMILTON MEDICAL
    • 10.1.15.1 Business overview
    • 10.1.15.2 Products offered
• 10.2 OTHER PLAYERS
  • 10.2.1 NATUS MEDICAL
  • 10.2.2 SPACELABS HEALTHCARE
  • 10.2.3 VENTEC LIFE SYSTEMS
  • 10.2.4 PHOENIX MEDICAL SYSTEMS
  • 10.2.5 NONIN
  • 10.2.6 ANALOGIC CORPORATION
  • 10.2.7 VYAIRE MEDICAL
  • 10.2.8 VYGON GROUP
  • 10.2.9 COOK
  • 10.2.10 APEX MEDICAL DEVICES

11 APPENDIX

• 11.1 DISCUSSION GUIDE
• 11.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 11.3 CUSTOMIZATION OPTIONS
• 11.4 RELATED REPORTS
• 11.5 AUTHOR DETAILS